No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
www.cosmospc.co.jpNo one on the platform currently holds 3349.T.
No tracked institution reports a position in 3349.T as of their last filing.
No one on the platform has traded 3349.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 10.2% | 11.5% | 14.3% | — | — | — |
| Rev. Growth % | 8.7% | 8.6% | ||||
| Profit Margin % | 2.9% | 2.9% | 3.1% | |||
| Free Cash Flow Margin % | -1.1% | -0.1% | 0.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $1.19T | +8.5% | $403.66 | $388.66–$421.33 | — | 10 |
| 2028 | $1.28T | +7.8% | $429.93 | $414.73–$450.03 | — | 10 |
| 2029 | $1.37T | +7.2% | $462.85 | $436.44–$482.73 | — | 8 |
| 2030 | $1.49T | +8.8% | $515.00 | $496.32–$525.24 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-13 | $119.62 | $117.31 | -1.9% |
| 2026-04-13 | $102.66 | $102.20 | -0.4% |
| 2026-01-13 | $84.01 | $81.73 | -2.7% |
| 2025-10-14 | $112.02 | $105.73 | -5.6% |
| 2025-07-11 | $112.38 | $108.95 | -3.1% |
| 2025-04-14 | $72.06 | $94.19 | +30.7% |
| 2025-01-10 | $73.42 | $79.31 | +8.0% |
| 2024-10-11 | $88.69 |
| $102.74 |
| +15.8% |
| $1743.00 |
| +1.04% |
| $560.7B |
| — |
| 7459.TMediPal Holdings Corporation | $2938.50 | +1.82% | $601.5B | — |
| 7649.TSugi Holdings Co.,Ltd. | $1297.50 | +2.65% | $482.8B | — |
Source: Financial Modeling Prep · peers by sector/industry